Entera Bio Ltd.
ENTX
$1.21
$0.010.83%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | 0.00 | -- | -- | 42.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 0.00 | -- | -- | 42.00K |
| Cost of Revenue | -- | 0.00 | -- | -- | 42.00K |
| Gross Profit | -- | 0.00 | -- | -- | 0.00 |
| SG&A Expenses | 1.29M | 1.32M | 1.61M | 1.15M | 1.44M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.54M | 3.04M | 3.26M | 2.67M | 2.61M |
| Operating Income | -3.54M | -3.04M | -3.26M | -2.67M | -2.56M |
| Income Before Tax | -3.51M | -3.02M | -3.20M | -2.66M | -2.57M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.51M | -3.02M | -3.20M | -2.66M | -2.57M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.51M | -3.02M | -3.20M | -2.66M | -2.57M |
| EBIT | -3.54M | -3.04M | -3.26M | -2.67M | -2.56M |
| EBITDA | -3.53M | -3.04M | -3.25M | -2.66M | -2.56M |
| EPS Basic | -0.07 | -0.06 | -0.07 | -0.06 | -0.06 |
| Normalized Basic EPS | -0.05 | -0.04 | -0.04 | -0.04 | -0.04 |
| EPS Diluted | -0.07 | -0.06 | -0.07 | -0.06 | -0.06 |
| Normalized Diluted EPS | -0.05 | -0.04 | -0.04 | -0.04 | -0.04 |
| Average Basic Shares Outstanding | 47.76M | 47.28M | 47.09M | 46.84M | 43.38M |
| Average Diluted Shares Outstanding | 47.76M | 47.28M | 47.09M | 46.84M | 43.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |